Medication info
Oneverol Tablets (Carvedilol)

Oneverol Tablets (Carvedilol)

Prescription medicationTabletOral
Ingredient · strength
Carvedilol›25mg / 1 tablet
Manufacturer / importer
Daewon Pharmaceutical Co., Ltd.
Appearance
White round tablets
Packaging
90 tablets (10 tablets/ PTP X 9)
Approval status
Active

MFDS item code 200101634 · Notified 2001.06.19 · Insurance code 671802420

Summary

Main use
Adjunctive treatment of congestive heart failure; treatment of essential hypertension and chronic stable angina
Who takes it
Adults
Adult dose
Do not increase the dose or stop taking this medicine without a doctor's instructions. 1. Essential hypertension 1) Adults (1) For the first 2 days, administer 12.5 mg of carvedilol orally once daily, then administer 25 mg orally once daily. (2) The usual dose is 25 mg orally once daily for 2 weeks. If an increase is needed, increase to 25 mg twice daily. The maximum dose per administration is 25 mg, and the maximum daily dose is 50 mg. 2) Older adults In some older adults, 12.5 mg once daily may be sufficient to achieve an adequate response. If the response is inadequate after 2 weeks of treatment, the dose may be increased. 2. Chronic stable angina 1) For the first 2 days, administer 12.5 mg of this medicine per dose orally twice daily, then administer 25 mg per dose orally twice daily. 2) The usual dose is 25 mg per dose twice daily for 2 weeks. If an increase is needed (excluding older adults), the dose may be increased to 50 mg twice daily. 3. Congestive heart failure Before starting treatment with this medicine, the patient's existing standard therapy (conventional treatment for chronic heart failure with an ACE inhibitor, diuretic, and usually a digitalis preparation) should be stable. Fluid retention should also be minimized before starting treatment with this medicine. 1) The usual initial dose is 3.125 mg of this medicine per dose orally twice daily for 2 weeks. If the patient tolerates this treatment well, increase the dose to 6.25 mg twice daily for 2 weeks, then increase to 12.5 mg twice daily for 2 weeks, and then increase to 25 mg twice daily. 2) Increase the dose gradually after taking each dose level for at least 2 weeks, up to the dose tolerated by the patient. 3) The effective minimum dose is 6.25 mg per dose twice daily. The maximum dose is 25 mg per dose twice daily for patients weighing 85 kg or less, and 50 mg per dose twice daily for patients weighing more than 85 kg. 4) To control the rate of absorption, it is recommended to take the medicine with meals in the morning and evening. Taking it with meals slows the rate of absorption and may reduce the incidence of orthostatic hypotension.

Ingredients

Manufacturer
Daewon Pharmaceutical Co., Ltd.

Efficacy & effects

Adjunctive treatment of congestive heart failure; treatment of essential hypertension and chronic stable angina

  • Essential hypertension
  • chronic stable angina
  • congestive heart failure
View approved original text

This medication is used for the treatment of essential hypertension, chronic stable angina, and congestive heart failure. It is especially effective as an adjunct treatment when used together with diuretics, digitalis preparations, ACE inhibitors, and other vasodilators. By doing so, it helps control blood pressure and reduces the strain on the heart, alleviating symptoms. It should be used appropriately according to the patient's condition.

How to take

Adult dose

Do not increase the dose or stop taking this medicine without a doctor's instructions. 1. Essential hypertension 1) Adults (1) For the first 2 days, administer 12.5 mg of carvedilol orally once daily, then administer 25 mg orally once daily. (2) The usual dose is 25 mg orally once daily for 2 weeks. If an increase is needed, increase to 25 mg twice daily. The maximum dose per administration is 25 mg, and the maximum daily dose is 50 mg. 2) Older adults In some older adults, 12.5 mg once daily may be sufficient to achieve an adequate response. If the response is inadequate after 2 weeks of treatment, the dose may be increased. 2. Chronic stable angina 1) For the first 2 days, administer 12.5 mg of this medicine per dose orally twice daily, then administer 25 mg per dose orally twice daily. 2) The usual dose is 25 mg per dose twice daily for 2 weeks. If an increase is needed (excluding older adults), the dose may be increased to 50 mg twice daily. 3. Congestive heart failure Before starting treatment with this medicine, the patient's existing standard therapy (conventional treatment for chronic heart failure with an ACE inhibitor, diuretic, and usually a digitalis preparation) should be stable. Fluid retention should also be minimized before starting treatment with this medicine. 1) The usual initial dose is 3.125 mg of this medicine per dose orally twice daily for 2 weeks. If the patient tolerates this treatment well, increase the dose to 6.25 mg twice daily for 2 weeks, then increase to 12.5 mg twice daily for 2 weeks, and then increase to 25 mg twice daily. 2) Increase the dose gradually after taking each dose level for at least 2 weeks, up to the dose tolerated by the patient. 3) The effective minimum dose is 6.25 mg per dose twice daily. The maximum dose is 25 mg per dose twice daily for patients weighing 85 kg or less, and 50 mg per dose twice daily for patients weighing more than 85 kg. 4) To control the rate of absorption, it is recommended to take the medicine with meals in the morning and evening. Taking it with meals slows the rate of absorption and may reduce the incidence of orthostatic hypotension.

Precautions

This medication is often contraindicated in certain patients; for example, those who have allergies to this drug or its components, patients with severely impaired cardiac function, patients with asthma or severe respiratory disorders, and those with severe liver dysfunction should not receive it. Additionally, patients with diabetes, elderly individuals, and those with reduced kidney function should take special precautions when using this medication and should regularly monitor their blood pressure and cardiac condition. The drug can affect the central nervous system, leading to symptoms such as dizziness, headache, and fatigue, and may cause a slow heart rate or low blood pressure; therefore, if symptoms are severe, immediate consultation with a physician is necessary. Do not suddenly discontinue the medication while on it; doses should be gradually reduced under medical supervision, especially in patients with heart diseases, as abrupt withdrawal may worsen symptoms. This medication can interact with other drugs, so patients should inform their physician or pharmacist of any other medications they are taking. Caution is especially necessary when taken alongside antihypertensives, antidiabetics, cardiac medications, and sedatives. It is safer for pregnant or breastfeeding women not to use this medication, and its safety and efficacy in children and adolescents have not been adequately established. In case of overdose, there is a risk of severe hypotension, cardiac arrhythmias, and respiratory distress, so treatment should be sought immediately at a hospital, as this drug is not easily removed by dialysis. When storing this medication, keep it in a container that protects it from light exposure, and make sure to store it in a place out of reach of children. It is advisable to avoid transferring it to other containers.

Side effects

  • Dizziness
  • headache
  • fatigue
  • weakness
  • hallucinations
  • confusion
  • depression
  • sleep disorders
  • nightmares
  • psychosis
Show 59 more
  • severe bradycardia
  • shock
  • complete atrioventricular block
  • heart failure
  • cardiac arrest
  • hypotension
  • loss of consciousness
  • decreased pulse rate
  • cold extremities
  • edema
  • ventricular standstill
  • worsening renal function
  • renal failure
  • increased airway resistance
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • constipation
  • hives
  • itching
  • lichenoid reaction
  • sweating
  • allergic rash
  • changes in serum amino transferase
  • thrombocytopenia
  • leukopenia
  • hypoglycemia
  • masked hyperthyroidism
  • hyperglycemia
  • weight gain
  • increased blood cholesterol
  • bradycardia
  • hypotension
  • shortness of breath
  • hypertension in angina
  • liver dysfunction
  • jaundice
  • limb pain
  • decreased tears
  • sensory disturbances
  • visual disturbances
  • eye irritation
  • dry mouth
  • urinary disorder
  • sexual dysfunction
  • allergic reactions
  • toxic epidermal necrolysis
  • Stevens-Johnson syndrome
  • hypotension
  • decreased heart rate
  • myocardial weakness
  • ventricular standstill
  • cardiogenic shock
  • respiratory distress
  • bronchospasm
  • vomiting
  • consciousness disorder
  • generalized seizure

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a light-protective container. Additionally, it is best to keep the medication at room temperature between 1 to 30 degrees Celsius. This helps maintain the drug's efficacy for a longer period.

Appearance and packaging

Appearance

White round tablets

Package unit

90 tablets (10 tablets/ PTP X 9)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.